Trials / Completed
CompletedNCT00140946
A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Two-Period, Parallel-group Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 546 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A study to assess the clinical effect of montelukast sodium with concomitant administration of inhaled budesonide in asthmatic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476; montelukast sodium/Duration of Treatment: 16 weeks | |
| DRUG | Comparator: placebo / Duration of Treatment: 16 weeks |
Timeline
- Start date
- 1998-03-01
- Primary completion
- 2000-10-01
- Completion
- 2000-10-01
- First posted
- 2005-09-01
- Last updated
- 2022-02-02
Source: ClinicalTrials.gov record NCT00140946. Inclusion in this directory is not an endorsement.